Allows self declaration on portal for licensing purposes
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business. The company selling prescription drugs and medical devices will keep Johnson & Johnson as its name, the company said Friday. The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnson's, and Band-Aid. A name was not disclosed for the new company. Details are sparse, but the company expect the split to occur in the next two years. The announcement comes just days after General Electric said that it plans to split into three separate companies.
The world's largest standalone medical device maker said it would not provide a forecast for 2021 due to uncertainties surrounding the Covid-19 pandemic
Developed by students at IIT Madras, the device is can be customised and mass-produce and is likely to be priced as low as Rs 15,000
This period is to allow all manufacturers to clear current stock of their packing material with current MRPs and enable a smooth transition
Notification mandates inspection of all Indian manufacturing units by drug controlling authorities
MTAI says market access should be on the basis of the quality of medical devices
Officials declined to say when the draft would be finalised or when it could go to Parliament